Caliway Biopharmaceuticals Co (ROCO:6919) 3-Year Revenue Growth Rate : 17.40% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Caliway Biopharmaceuticals Co 3-Year Revenue Growth Rate?

Caliway Biopharmaceuticals Co's Revenue per Share for the six months ended in Dec. 2023 was NT$0.19.

During the past 12 months, Caliway Biopharmaceuticals Co's average Revenue per Share Growth Rate was 188.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 17.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 5 years, the highest 3-Year average Revenue per Share Growth Rate of Caliway Biopharmaceuticals Co was 17.40% per year. The lowest was -41.00% per year. And the median was -11.80% per year.

Competitive Comparison of Caliway Biopharmaceuticals Co's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Caliway Biopharmaceuticals Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Caliway Biopharmaceuticals Co's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Caliway Biopharmaceuticals Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Caliway Biopharmaceuticals Co's 3-Year Revenue Growth Rate falls into.

Caliway Biopharmaceuticals Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Caliway Biopharmaceuticals Co (ROCO:6919) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Caliway Biopharmaceuticals Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Caliway Biopharmaceuticals Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Caliway Biopharmaceuticals Co (ROCO:6919) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Caliway Biopharmaceuticals Co Ltd (ROCO:6919) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.99, Sec. 1, Xintai 5th Road, 32F.-9, Xizhi District, New Taipei City, TWN, 221

Website

https://www.caliway.com.tw

Caliway Biopharmaceuticals Co Ltd is specialized in the development of new drugs for medical aesthetic and inflammatory diseases. Its leading candidate, CBL-514, is a new drug that can trigger adipocyte apoptosis at the injection site and effectively reduce subcutaneous fat without causing tissue necrosis or prominent side effects.

Caliway Biopharmaceuticals Co (ROCO:6919) Headlines

No Headlines